NIH Funding Opportunities (Notices, PA, RFA)

Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 2 hours 35 min ago
Notice of Change to PAR-20-101 "Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed)"
Notice NOT-HD-22-007 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Request for Public Comments on DRAFT Supplemental Information to the NIH Policy for Data Management and Sharing: Protecting Privacy When Sharing Human Research Participant Data
Notice NOT-OD-22-131 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Point-of-Care Technologies Research Network Centers (U54 Clinical Trial Optional)
Notice NOT-EB-22-001 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-22-037 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications focused on advancing development of vaccine candidates against Enterotoxigenic Escherichia coli (ETEC), Salmonella enterica serotype Paratyphi A, and two Shigella species, Shigella flexneri and S. sonnei.
Categories: Job Watch, Literature Watch
Educational Hub for Enhancing Diversity in Computational Genomics and Data Science (U24 Clinical Trials Not Allowed)
Funding Opportunity RFA-HG-22-002 from the NIH Guide for Grants and Contracts. To integrate and disseminate resources for cloud-based education in computational genomics and data science in institutions serving students from underrepresented populations in these topics, and act as a facilitator for faculty in such institutions to create courses in these topics.
Categories: Job Watch, Literature Watch
Notice of Change Key Dates for PAR-20-111 "Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)"
Notice NOT-NS-22-097 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change Key Dates for PAR-20-122 "Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)"
Notice NOT-NS-22-098 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to PAR-20-238, "Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)"
Notice NOT-DA-22-068 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Clarification and Guidance for Applicants Preparing Applications for the Summer 2022 Due Dates During the COVID-19 Pandemic
Notice NOT-OD-22-112 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
Funding Opportunity PAR-22-105 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. All applications must be within the scope of the mission of one of the Institutes/Centers listed above.
Categories: Job Watch, Literature Watch
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
Funding Opportunity PAR-22-109 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. All applications must be within the scope of the mission of one of the Institutes/Centers listed above.
Categories: Job Watch, Literature Watch
Updated Requirements for NIH Notification of Removal or Disciplinary Action Involving Program Directors/Principal Investigators or other Senior/Key Personnel
Notice NOT-OD-22-129 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-160 from the NIH Guide for Grants and Contracts. The goal of this funding opportunity announcement is to support meritorious research projects that involve secondary statistical analyses of existing dental, oral or craniofacial database resources, or that develop needed statistical methodology for analyzing existing dental, oral or craniofacial databases.
Categories: Job Watch, Literature Watch
Updated NHLBI Guidance Concerning Mentored Career Development (K08 and K23) Awards: Percent Effort
Notice NOT-HL-22-022 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Availability of FAQ for RFA-MH-22-110 and RFA-MH-22-111: Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes Consortium
Notice NOT-MH-22-240 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Legislative Mandates in Effect for FY 2022
Notice NOT-OD-22-117 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
Funding Opportunity PAR-22-167 from the NIH Guide for Grants and Contracts. The Clinical and Translational Science Award (CTSA) Program Collaborative and Innovative Acceleration Award (CCIA) supports synergistic activities that accelerate the translational research process through collaboration and innovation. This funding opportunity announcement (FOA) invites applications to develop, demonstrate and disseminate innovative solutions to transform the field of translational science by addressing the inefficiencies that are common across diseases and bringing more interventions to all people more quickly through collaborative science among the CTSA Program hubs, NIH Institutes, Centers, Offices (ICOs) and/or external stakeholders.
Categories: Job Watch, Literature Watch
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-106 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. All applications must be within the scope of the mission of one of the Institutes/Centers listed above.
Categories: Job Watch, Literature Watch
Notice of Clarification for PAS-21-245 Limited Competition: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)
Notice NOT-AR-22-021 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to Foreign Component Eligibility in PAR-20-217, PAR-20-218, and PAR-21-240
Notice NOT-AT-22-023 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch